Metric has launched a decentralized exchange (DEX) that operates across Robinhood Chain, BNB Chain, and Ethereum. This expansion extends Metric's initial plan, which focused solely on Robinhood Chain, an Ethereum-based Layer 2 network using Arbitrum technology. Users can now trade, provide liquidity, and create their own pools on all three networks, enhancing cross-chain trading opportunities. Robinhood Chain's public mainnet launched on July 1, 2026, marking a significant step in Layer 2 adoption.
Metric's launch of a decentralized exchange (DEX) across Robinhood Chain, BNB Chain, and Ethereum coincides with a strong market breadth on Pluang, where 45 out of 50 major cryptocurrencies rose as of Oct 16, 2026 16:31 WIB. Among notable movers, UNI (Uniswap) increased by 6.81% to Rp133.272 with a typical hold time of 65 days and a Pluang order activity split of 44% Sell / 56% Buy. SUSHI (SushiSwap) rose 6.60% to Rp4.157, while AVAX (Avalanche) climbed 6.47% to Rp183.291, showing significant buying interest with 91% buy orders.
NeOnc Technologies reported early clinical improvement in a critically ill three-year-old boy with an aggressive brain tumor treated with investigational intranasal NEO100 under compassionate use in Abu Dhabi. The child is now breathing independently...
TransUnion's Branded Call Display, a solution that helps consumers identify legitimate callers and avoid robocall fraud, has been named one of TIME's Best Inventions of 2026 in the Connectivity & Communication category. The technology displays a busi...
La Rosa Holdings Corp. will change its name to Stratum Holdings Corp. on October 19, 2026, reflecting its shift from real estate services to an AI infrastructure company specializing in GPU leasing and high-performance computing. The company recently...
ASUS has released the ProArt P16 and P14 laptops in Canada, powered by NVIDIA RTX Spark technology. These laptops feature up to 128GB of unified memory and advanced AI capabilities designed for creators, AI developers, and workflow builders, enabling...
OXB, a global cell and gene therapy CDMO, has appointed Dr Joachim Kreuzburg as an Independent Non-Executive Director effective November 23, 2026. Dr Kreuzburg brings over 20 years of leadership in life sciences, notably transforming Sartorius AG int...
